Systematic Review Confirms Soy Isoflavones Have No Estrogenic Effects in Postmenopausal Women, Supporting Their Role as Selective Estrogen Receptor Modulators

A recent systematic review by Dr. Laura Chiavaroli's lab with data from 40 RCTs with certainty of evidence high-to-moderate for all outcomes provides strong evidence that soy isoflavones do not exhibit estrogenic effects in postmenopausal women. The study supports the idea that soy isoflavones act as selective estrogen receptor modulators, differing from estrogen. This research promotes soy as a high-quality, environmentally sustainable plant protein, with potential health benefits for postmenopausal women. These findings align with sustainable dietary guidelines and help alleviate concerns about soy's role in estrogen-dependent health issues.

For more details, visit the full article here.